Nicotine-induced retardation of chondrogenesis through down-regulation of IGF-1 signaling pathway to inhibit matrix synthesis of growth plate chondrocytes in fetal rats

Toxicol Appl Pharmacol. 2013 May 15;269(1):25-33. doi: 10.1016/j.taap.2013.02.008. Epub 2013 Feb 27.

Abstract

Previous studies have confirmed that maternal tobacco smoking causes intrauterine growth retardation (IUGR) and skeletal growth retardation. Among a multitude of chemicals associated with cigarette smoking, nicotine is one of the leading candidates for causing low birth weights. However, the possible mechanism of delayed chondrogenesis by prenatal nicotine exposure remains unclear. We investigated the effects of nicotine on fetal growth plate chondrocytes in vivo and in vitro. Rats were given 2.0 mg/kg·d of nicotine subcutaneously from gestational days 11 to 20. Prenatal nicotine exposure increased the levels of fetal blood corticosterone and resulted in fetal skeletal growth retardation. Moreover, nicotine exposure induced the inhibition of matrix synthesis and down-regulation of insulin-like growth factor 1 (IGF-1) signaling in fetal growth plates. The effects of nicotine on growth plates were studied in vitro by exposing fetal growth plate chondrocytes to 0, 1, 10, or 100 μM of nicotine for 10 days. Nicotine inhibited matrix synthesis and down-regulated IGF-1 signaling in chondrocytes in a concentration-dependent manner. These results suggest that prenatal nicotine exposure induces delayed chondrogenesis and that the mechanism may involve the down-regulation of IGF-1 signaling and the inhibition of matrix synthesis by growth plate chondrocytes. The present study aids in the characterization of delayed chondrogenesis caused by prenatal nicotine exposure, which might suggest a candidate mechanism for intrauterine origins of osteoporosis and osteoarthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone and Bones / drug effects
  • Bone and Bones / embryology
  • Cells, Cultured
  • Chondrocytes / drug effects*
  • Chondrocytes / metabolism
  • Chondrocytes / pathology
  • Chondrogenesis / drug effects*
  • Corticosterone / blood
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Extracellular Matrix / metabolism*
  • Female
  • Fetal Blood / metabolism
  • Fetal Weight / drug effects
  • Gestational Age
  • Growth Plate / drug effects*
  • Growth Plate / embryology
  • Growth Plate / metabolism
  • Growth Plate / pathology
  • Injections, Subcutaneous
  • Insulin-Like Growth Factor I / metabolism*
  • Male
  • Maternal Exposure
  • Nicotine / administration & dosage
  • Nicotine / toxicity*
  • Nicotinic Agonists / administration & dosage
  • Nicotinic Agonists / toxicity*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Time Factors

Substances

  • Nicotinic Agonists
  • insulin-like growth factor-1, rat
  • Insulin-Like Growth Factor I
  • Nicotine
  • Corticosterone